share_log

DEF 14A: Definitive information statements

DEF 14A: Definitive information statements

DEF 14A:股东委托书决议
美股SEC公告 ·  10/15 15:50

Moomoo AI 已提取核心信息

60 Degrees Pharmaceuticals, Inc. (60P) has announced a Special Meeting of Stockholders to be held virtually on November 6, 2024. The meeting will address several key proposals, including the exercise of warrants issued on September 5, 2024, to purchase up to 6,014,493 shares of common stock, an amendment to increase the number of shares available under the 2022 Equity Incentive Plan by 500,000 shares, and an amendment for a reverse stock split of common stock at a ratio ranging from 1:3 to 1:5 as determined by the Board. Additionally, the meeting will consider adjourning if necessary to solicit more proxies if there are insufficient votes for the proposals. The Special Meeting is a response to the Private Placement transaction closed on September 5, 2024, involving Series A and Series B warrants purchased by...Show More
60 Degrees Pharmaceuticals, Inc. (60P) has announced a Special Meeting of Stockholders to be held virtually on November 6, 2024. The meeting will address several key proposals, including the exercise of warrants issued on September 5, 2024, to purchase up to 6,014,493 shares of common stock, an amendment to increase the number of shares available under the 2022 Equity Incentive Plan by 500,000 shares, and an amendment for a reverse stock split of common stock at a ratio ranging from 1:3 to 1:5 as determined by the Board. Additionally, the meeting will consider adjourning if necessary to solicit more proxies if there are insufficient votes for the proposals. The Special Meeting is a response to the Private Placement transaction closed on September 5, 2024, involving Series A and Series B warrants purchased by institutional investors and placement agent warrants issued to H.C. Wainwright & Co., LLC. The Board has approved the proposals, believing they are in the best interests of the company and its stockholders. The meeting will be accessible via telephone, with no in-person attendance. Stockholders of record as of September 20, 2024, are entitled to vote, and the company encourages voting as soon as possible by telephone or by mailing a proxy card.
60度制药公司(60P)宣布将于2024年11月6日虚拟举行股东大会。会议将讨论几项关键提案,包括行使于2024年9月5日发行的认股权,以购买高达6,014,493股普通股,修正增加2022年股权激励计划可供使用的股份数量至额外500,000股,以及就普通股进行1:3至1:5不等比例的股票拆分提案进行修正,由董事会确定。此外,如果提案获得的选票不足,会议将考虑延期以征求更多代理人。这次股东大会是对2024年9月5日结束的定向增发交易作出的回应,涉及机构投资者购买的A轮和B轮认股权以及发给H.C. Wainwright & Co.,LLC的放置代理认股权。董事会已经批准了这些提案,认为它们符合公司及股东的最佳利益。会议可通过电话进行访问,不允许现场参与。截至2024年9月20日的股东享有投票权,公司鼓励尽快通过电话或邮寄代理卡进行投票。
60度制药公司(60P)宣布将于2024年11月6日虚拟举行股东大会。会议将讨论几项关键提案,包括行使于2024年9月5日发行的认股权,以购买高达6,014,493股普通股,修正增加2022年股权激励计划可供使用的股份数量至额外500,000股,以及就普通股进行1:3至1:5不等比例的股票拆分提案进行修正,由董事会确定。此外,如果提案获得的选票不足,会议将考虑延期以征求更多代理人。这次股东大会是对2024年9月5日结束的定向增发交易作出的回应,涉及机构投资者购买的A轮和B轮认股权以及发给H.C. Wainwright & Co.,LLC的放置代理认股权。董事会已经批准了这些提案,认为它们符合公司及股东的最佳利益。会议可通过电话进行访问,不允许现场参与。截至2024年9月20日的股东享有投票权,公司鼓励尽快通过电话或邮寄代理卡进行投票。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息